Correlation Between Purple Biotech and Evogene

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Purple Biotech and Evogene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Purple Biotech and Evogene into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Purple Biotech and Evogene, you can compare the effects of market volatilities on Purple Biotech and Evogene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Purple Biotech with a short position of Evogene. Check out your portfolio center. Please also check ongoing floating volatility patterns of Purple Biotech and Evogene.

Diversification Opportunities for Purple Biotech and Evogene

-0.16
  Correlation Coefficient

Good diversification

The 3 months correlation between Purple and Evogene is -0.16. Overlapping area represents the amount of risk that can be diversified away by holding Purple Biotech and Evogene in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evogene and Purple Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Purple Biotech are associated (or correlated) with Evogene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evogene has no effect on the direction of Purple Biotech i.e., Purple Biotech and Evogene go up and down completely randomly.

Pair Corralation between Purple Biotech and Evogene

Given the investment horizon of 90 days Purple Biotech is expected to generate 1.73 times more return on investment than Evogene. However, Purple Biotech is 1.73 times more volatile than Evogene. It trades about -0.02 of its potential returns per unit of risk. Evogene is currently generating about -0.04 per unit of risk. If you would invest  3,740  in Purple Biotech on November 4, 2024 and sell it today you would lose (3,414) from holding Purple Biotech or give up 91.28% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Purple Biotech  vs.  Evogene

 Performance 
       Timeline  
Purple Biotech 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Purple Biotech are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak fundamental drivers, Purple Biotech unveiled solid returns over the last few months and may actually be approaching a breakup point.
Evogene 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Evogene has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in March 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Purple Biotech and Evogene Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Purple Biotech and Evogene

The main advantage of trading using opposite Purple Biotech and Evogene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Purple Biotech position performs unexpectedly, Evogene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evogene will offset losses from the drop in Evogene's long position.
The idea behind Purple Biotech and Evogene pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Complementary Tools

Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Transaction History
View history of all your transactions and understand their impact on performance